OIS Q1 2026 Earnings EPS Slightly Exceeds Estimates Amid Mixed Market Conditions Grace Therapeutics Q1 2026 Earnings EPS Surprise of 5098 Despite No Revenue as Stock Declines Evergy Q1 2026 Earnings EPS Beats Estimates with 458 Surprise WFG Q1 2026 Earnings EPS Beats Estimates Significantly Despite Loss SPME Q1 2026 Earnings EPS Misses Estimates Preferred Shares Dip C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution